Screener
Coherus BioSciences CHRS Q1 2025 earnings
Reported May 12, 2025 · After market close
Revenue$7.6MMiss by $53.4M
EPS-$0.35Miss by $0.04
Revenue estimate$61.0M
EPS estimate-$0.31
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$16.0M
EPS estimate-$0.21
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Coherus BioSciences report Q1 2025 earnings?
- Coherus BioSciences (CHRS) reported Q1 2025 earnings on May 12, 2025 after market close.
- What were Coherus BioSciences's Q1 2025 revenue and EPS?
- Coherus BioSciences reported revenue of $7.6M and eps of $-0.35 for Q1 2025.
- Did Coherus BioSciences beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $61.0M by $53.4M. EPS missed the consensus estimate of $-0.31 by $0.04.
- How did Coherus BioSciences's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 90.1% from $77.1M a year earlier and eps declined 9.4% from $-0.32.
- Where can I find Coherus BioSciences's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0001558370-25-007410) and the 10-Q periodic report (0001558370-25-007418) directly on SEC EDGAR. The filing index links above go to sec.gov.
